Molly K. Colvin

Molly K. Colvin

Auto-generated profile, based on publicly available information

Molly K. Colvin

Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2021 in The Clinical Neuropsychologist
Verified
Journal Article
Closed access
MCMary K. (Molly) Colvin
Mary K. (Molly) Colvin
JRJennifer Reesman
Jennifer Reesman
TGTannahill Glen
Tannahill Glen
The coronavirus 19 (COVID-19) pandemic resulted in educational disruption of historic breadth and duration. The authors describe early studies and interim standardized assessment reports to highlig...

1 October 2018 in Pediatrics
Verified
Journal Article
Closed access
PDF file
MCMary K. Colvin
Mary K. Colvin
JPJames Poysky
James Poysky
KKKathi Kinnett
Kathi Kinnett
MDMario Damiani
Mario Damiani
MGMelissa Gibbons
Melissa Gibbons
NWNorbert Weidner
Norbert Weidner
In this article, we outline a comprehensive plan for the psychosocial management of patients with Duchenne muscular dystrophy (DMD) across the life span. In 2010, the Centers for Disease Control and Prevention sponsored the development of multidisciplinary management guidance for DMD, and in 2018, that guidance was updated. In the intervening years, a new emphasis was placed on studying and addressing the psychosocial issues that affect patients with DMD, driven in part by improved patient survival. Once viewed as ancillary to managing the significant medical needs of patients with DMD, it is now standard practice to integrate psychosocial management into the multidisciplinary management of the disease. It is also increasingly recognized that neurodevelopmental disorders in DMD occur at a higher rate than what was previously understood and that these disorders warrant early and intensive intervention. In this article, we expand on the content found in the 2018 DMD Care Considerations.

1 June 2020 in Cognitive and Behavioral Neurology
Verified
Journal Article
Closed access
PAPriyanka R. Alluri
Priyanka R. Alluri
JSJuliet Solit
Juliet Solit
CLCatherine L. Leveroni
Catherine L. Leveroni
KGKatherine Goldberg
Katherine Goldberg
JVJulia V. Vehar
Julia V. Vehar
DPDavid L. Perez
David L. Perez
Functional neurological (conversion) disorder (FND) is a neuropsychiatric condition characterized by sensorimotor symptoms exhibiting features incompatible with other neurologic diseases. Individuals with motor FND (mFND) typically present with limb weakness, nonepileptic seizures, and/or abnormal movements. However, this population also frequently reports clouded thinking, inattention, and memory difficulties. Cognitive complaints in individuals with mFND are important to evaluate as they may negatively impact quality of life and impede treatment engagement. We provide a narrative review of the neuropsychological testing literature detailing neurocognitive profiles of individuals with mFND. We also present three illustrative clinical cases at the intersection of mFND and cognitive concerns. Several studies and our case examples highlight that generally normal cognitive performance can be observed concurrently with subjective cognitive complaints in some individuals with mFND; this mismatch may be a possible “rule-in” sign of functional cognitive symptoms. Other studies have reported impairments in attention, memory, language, visuospatial, and executive functioning in individuals with mFND. These impairments could be related to medical-psychiatric comorbidities, psychotropic medication side effects, and intrinsic disease mechanisms. When evaluating individuals with mFND and their cognitive complaints, clinicians can use performance validity test and psychopathology findings to help them interpret the neuropsychological test results. Perceptual mismatches between intact objective cognitive performance and subjective cognitive complaints may reflect a negative attentional bias for cognitive abilities that can be targeted with cognitive retraining and cognitive behavioral therapy. Neuropsychological evaluations may provide a useful adjunctive tool clinicians can use to help assess individuals with mFND and cognitive concerns.

15 September 2023 in Archives of Clinical Neuropsychology
Verified
Journal Article
Closed access
PDF file
SSScott A Sperling
Scott A Sperling
SAShawn K Acheson
Shawn K Acheson
JFJoshua Fox-Fuller
Joshua Fox-Fuller
MCMary K Colvin
Mary K Colvin
LHLana Harder
Lana Harder
SGStephen R Gillaspy
Stephen R Gillaspy
Objective: The primary aim of this paper is to accelerate the number of randomized experimental studies of the reliability and validity in-home tele-neuropsychological testing (tele-np-t). Method: We conducted a critical review of the tele-neuropsychology literature. We discuss this research in the context of the United States’ public and private healthcare payer systems, including the Centers for Medicare & Medicaid Services (CMS) and Current Procedural Terminology (CPT) coding system’s telehealth lists, and existing disparities in healthcare access. Results: The number of tele-np publications has been stagnant since the onset of the COVID-19 pandemic. There are less published experimental studies of tele-neuropsychology (tele-np), and particularly in-home tele-np-t, than other tele-np publications. There is strong foundational evidence of the acceptability, feasibility, and reliability of tele-np-t, but relatively few studies of the reliability and validity of in-home tele-np-t using randomization methodology. Conclusions: More studies of the reliability and validity of in-home tele-np-t using randomization methodology are necessary to support inclusion of tele-np-t codes on the CMS and CPT telehealth lists, and subsequently, the integration and delivery of in-home tele-np-t services across providers and institutions. These actions are needed to maintain equitable reimbursement of in-home tele-np-t services and address the widespread disparities in healthcare access.

23 May 2024 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
ALAngela E. Lin
Angela E. Lin
ESEleanor R. Scimone
Eleanor R. Scimone
RTRobyn Thom
Robyn Thom
DBDuraisamy Balaguru
Duraisamy Balaguru
TKT. Bernard Kinane
T. Bernard Kinane
MGMGH Myhre Syndrome Study Group
MGH Myhre Syndrome Study Group

21 March 2018 in Cerebellum & Ataxias
Verified
Journal Article
Open access
PDF file
CHChelsea L. Hickey
Chelsea L. Hickey
JSJanet C. Sherman
Janet C. Sherman
PGPaula Goldenberg
Paula Goldenberg
AKAmy Kritzer
Amy Kritzer
PCPaul Caruso
Paul Caruso
MCMary K. Colvin
Mary K. Colvin
Joubert syndrome (JS) is a rare, autosomal recessively inherited genetic disorder characterized morphologically by unique developmental malformations of the cerebellum and brainstem (the molar tooth sign), and clinically by impaired motor functions and intellectual disability. Patients with JS often face multiple cognitive challenges, but the neuropsychological profile of this condition has not been well characterized. We performed comprehensive neurological and neuropsychological evaluations in three adult brothers with JS, ages 32, 27, and 25 years. They all exhibited impaired motor control, global developmental delay most evident in executive function, affect regulation, and social skill set, and similar patterns of neuropsychiatric symptoms. These findings provide new insights into the intellectual and neurobehavioral phenotype of JS, which we regard as a developmental form of the cerebellar cognitive affective / Schmahmann syndrome (CCAS). These observations have direct clinical relevance for the diagnosis and care of patients with JS, and they help further the understanding of the multiple manifestations of atypical cerebrocerebellar development.